A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a mouse model of TBI, researchers found the spray could reduce damage to the central nervous system and behavioral deficits, suggesting a potential therapeutic approach for TBI and other acute forms of brain injury.
Use of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with two other groups of diabetes drugs known as DPP-4 inhibitors and SGLT-2 inhibitors, finds a large study of U.K. health data published in the BMJ.
At a recent Nevada legislative committee hearing, lawmakers faced off with members of the governor’s administration over how to fill gaping holes in the state’s upcoming budget.
University of Queensland researchers have developed a new rapid sensor that can detect pregnancy complications, such as gestational diabetes, preterm birth risks and hypertension, as early as 11 weeks—with a simple blood test.
A one-hour adjustment to the clock on the wall may not sound dramatic. But our biological clock begs to differ.
For more than 15 years, Anthony Shum, MD, a pulmonologist at UC San Francisco, has tried to understand the random path of devastation that a rare genetic condition carves through the families it affects.
Mpox remains an international public health emergency, the World Health Organization said Thursday after deciding the epidemic still merits the highest level of alert, with cases rising and its geographic spread widening.
The US Food and Drug Administration has unexpectedly canceled a meeting with experts to discuss the development of next year’s flu vaccines, media reported late Wednesday.
Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but because of its potential drawbacks and costs, patients and caregivers often face the difficult decision of whether to undergo the procedure. However, new research suggests that earlier BMT may provide protection from stroke later in life.
An intensive therapy for children with neuromotor disorders developed by Virginia Tech researchers shows promise for kids with a rare genetic mutation, a new study has found.